14th to 17th September 2015 AstraZeneca, Alderley Park, Macclesfield, UK. Piet van der Graaf (Leiden)         Oleg Demin (Moscow)           Sandra Visser (Merck)           Blanca Rodriguez (Oxford) This 4 day meeting, kindly supported by AstraZeneca, Pfizer and Unilever, provided an introduction to QSP and a forum for researchers in academia and industry to come together to discuss developments in this emerging field of science in the UK and internationally. The meeting showcased current advances in the field (Day 1) and provided the opportunity for mathematicians, engineers, scientists and industrialists to exchange skills and knowledge by working on problems brought by life scientists in industry and academia (Days 2 to 4). Programme Problem descriptions & Final reports An abstract modelling framework for adverse outcome pathways. A copy of the problem report can be downloaded here Understanding polypharmacology of antibodies: what are the benefits of using a bispecific vs combination of monospecifics? A copy of the problem report can be downloaded here Modelling Cancer Immunotherapy. A copy of the problem report can be downloaded here Organising Committee: Marcus Tindall (Reading), Leon Aarons (Manchester), Mike Chappell (Warwick), Lourdes Cucurull-Sanchez (GlaxoSmithKline), Gianne Derks (Surrey), Pinky Dua (Pfizer), Ben Whalley (Reading) and James Yates (AstraZeneca). |